These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 10466059

  • 1. [Immunohistochemical study of p53 and Ki-67 antigen expression in bladder carcinoma].
    Yuge F, Hirakata H, Igarashi H, Kodama M, Kawata N, Takimoto Y.
    Hinyokika Kiyo; 1999 Jul; 45(7):453-6. PubMed ID: 10466059
    [Abstract] [Full Text] [Related]

  • 2. Prognostic significance of p53, bcl-2 and Ki-67 in high risk superficial bladder cancer.
    Stavropoulos NE, Filiadis I, Ioachim E, Hastazeris K, Tsimaris I, Kalogeras D, Stefanaki S, Agnantis NJ.
    Anticancer Res; 2002 Jul; 22(6B):3759-64. PubMed ID: 12552989
    [Abstract] [Full Text] [Related]

  • 3. The relationship of the histologic grade at the deep invasive front and the expression of Ki-67 antigen and p53 protein in oral squamous cell carcinoma.
    Kurokawa H, Zhang M, Matsumoto S, Yamashita Y, Tanaka T, Tomoyose T, Takano H, Funaki K, Fukuyama H, Takahashi T, Sakoda S.
    J Oral Pathol Med; 2005 Nov; 34(10):602-7. PubMed ID: 16202080
    [Abstract] [Full Text] [Related]

  • 4. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
    Haitel A, Posch B, El-Baz M, Mokhtar AA, Susani M, Ghoneim MA, Marberger M.
    J Urol; 2001 May; 165(5):1481-7. PubMed ID: 11342901
    [Abstract] [Full Text] [Related]

  • 5. Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67.
    Tut VM, Braithwaite KL, Angus B, Neal DE, Lunec J, Mellon JK.
    Br J Cancer; 2001 Jan; 84(2):270-5. PubMed ID: 11161387
    [Abstract] [Full Text] [Related]

  • 6. Biomarker study of primary nonmetastatic versus metastatic invasive bladder cancer. National Cancer Institute Bladder Tumor Marker Network.
    Lianes P, Charytonowicz E, Cordon-Cardo C, Fradet Y, Grossman HB, Hemstreet GP, Waldman FM, Chew K, Wheeless LL, Faraggi D.
    Clin Cancer Res; 1998 May; 4(5):1267-71. PubMed ID: 9607586
    [Abstract] [Full Text] [Related]

  • 7. Decreasing of p27(Kip1)and cyclin E protein levels is associated with progression from superficial into invasive bladder cancer.
    Kamai T, Takagi K, Asami H, Ito Y, Oshima H, Yoshida KI.
    Br J Cancer; 2001 May 04; 84(9):1242-51. PubMed ID: 11336477
    [Abstract] [Full Text] [Related]

  • 8. Tumor markers in stage P1 bladder cancer.
    Stavropoulos NE, Ioachim E, Charchanti A, Michael MC, Kitsiou E, Mihailidis I, Hastazeris K, Agnantis NJ.
    Anticancer Res; 2001 May 04; 21(2B):1495-8. PubMed ID: 11396238
    [Abstract] [Full Text] [Related]

  • 9. [Prognostic study of cell proliferative markers ki67, PCNA and p53 oncoprotein in bladder tumors].
    Ben Rejeb A, Mahjoub A, Berraies N, Tissaoui K.
    Ann Urol (Paris); 2000 Aug 04; 34(4):240-8. PubMed ID: 10994143
    [Abstract] [Full Text] [Related]

  • 10. Correlation between histological grade and MIB-1 and p53 immunoreactivity in meningiomas.
    Ozen O, Demirhan B, Altinörs N.
    Clin Neuropathol; 2005 Aug 04; 24(5):219-24. PubMed ID: 16167545
    [Abstract] [Full Text] [Related]

  • 11. Prognostic value of p53 and Ki-67 expression in resected or biopsy specimens of bile duct carcinoma.
    Murakami M, Sasaki T, Kuwada Y, Yamasaki S, Kuwahara K, Chayama K.
    Oncol Rep; 2003 Aug 04; 10(5):1091-6. PubMed ID: 12883663
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Immunohistochemical analysis of p53 and proliferating cell nuclear antigen (PCNA) in bladder cancer: positive immunostaining and radiosensitivity.
    Ogura K, Habuchi T, Yamada H, Ogawa O, Yoshida O.
    Int J Urol; 1995 Nov 04; 2(5):302-8. PubMed ID: 8749948
    [Abstract] [Full Text] [Related]

  • 14. Prognostic value of p53 and MIB-1 in transitional cell carcinoma of the urinary bladder with regional lymph node involvement.
    Frank I, Cheville JC, Blute ML, Lohse CM, Karnes RJ, Weaver AL, Sebo TJ, Nehra A, Zincke H.
    Cancer; 2004 Oct 15; 101(8):1803-8. PubMed ID: 15386300
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Plasmacytoid transitional cell carcinoma of urinary bladder: a clinicopathologic study of 9 cases.
    Ro JY, Shen SS, Lee HI, Hong EK, Lee YH, Cho NH, Jung SJ, Choi YJ, Ayala AG.
    Am J Surg Pathol; 2008 May 15; 32(5):752-7. PubMed ID: 18379419
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.